EnerSyn Global Inc. (ESYN)
ESYN trades on Nasdaq in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.03
+3.57% on the day
Market cap
$60.3M
Micro cap
Revenue · 2025
$867K
-30.8% on 2024
Net income · 2025
-$2.6M
-303.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ESYN on Nasdaq |
| Sector | Health Care |
| Industry | Other Pharmaceuticals |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001897245 |
| SEC industry code | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $867K |
| Net income | -$2.6M |
| Operating income | Not in SEC XBRL data |
| Net margin | -303.4% |
| Operating margin | Operating income not reported |
| Revenue growth | -30.8% |
| Cash | $2.1M |
| Total assets | $4.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 69.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-01-06 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-09-18 |
| Latest proxy | DEF 14A | 2025-10-09 |
Source: SEC EDGAR submissions feed, 267 recent filings. All filings on EDGAR.
Peers in Other Pharmaceuticals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| COSM | Cosmos Health Inc. | $0.3829 | +9.53% | $38.5M |
| ZSTK | ZeroStack Corp. | $4.37 | 0.00% | $95.4M |
| NUS | Nu Skin Enterprises Inc. | $5.01 | +2.88% | $243.9M |
| MEDS | DataMeds AI Inc. | $3.03 | -1.30% | $13.7M |
| HKPD | Cellyan Biotechnology Co. Ltd | $0.1049 | -1.59% | $5.1M |
| HLF | Herbalife Ltd. Common Shares | $14.21 | +4.41% | $1.5B |
| CAH | Cardinal Health Inc. | $239.72 | +0.69% | $55.5B |
| COR | Cencora Inc. | $330.11 | +1.55% | $63.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier